News
Resources
Blog
Sites
New report shows 3 in 10 Americans that have insurance still face a financial barrier to care
By Katie Koziara | October 7, 2021
Today, we released the results in the first report in a series on patient experiences with the health care system. The report, titled “Barriers to Health Care Access in the Patient Experience,”...
Read More
Industry leaders discuss the impact of the drug pricing debate
By Brian Newell | September 23, 2021
This month, PhRMA hosted a media briefing with leaders within the biopharmaceutical industry to discuss the dangers of current proposals on government price setting, while also sharing alternative...
Read More
Five reasons tying VA prices to Medicare Part D misses the mark
By Nicole Longo | September 22, 2021
Some members of Congress are considering a government “negotiation” plan that would tie medicine prices in Medicare to those in the U.S. Department of Veterans Affairs (VA). This misguided...
Read More
America’s biopharmaceutical companies to Congress: Government “negotiation” is the wrong approach
By Stephen J. Ubl | September 15, 2021
Today, PhRMA member companies made public an open letter to Capitol Hill to encourage Congress to abandon old partisan ideas on drug pricing and instead pursue policies that actually address what...
Read More
ICYMI: Event spotlights how we can make Medicare work better for patients
By Katie Koziara | August 4, 2021
Last month, PhRMA sponsored “Making Medicare Work Better for Patients,” an event hosted by The Hill. During the event, policymakers, patient advocates and biopharmaceutical leaders spoke about how...
Read More
The future of the rebate rule: Will policymakers stand with patients?
By Stephen J. Ubl | August 2, 2021
Policymakers will soon decide whether to stand by new Medicare changes that will help lower costs for beneficiaries at the pharmacy counter or abandon these changes to fund government programs...
Read More
Celebrating Medicare’s 56th anniversary
By Gabby Migliara | July 30, 2021
For 56 years, Medicare has helped pay for medical care for Americans over the age of 65, as well as younger Americans with certain medical needs. Today marks Medicare’s anniversary and to...
Read More
Ask About Adherence: 3 factors impacting medication adherence for patients with diabetes and how our proactive affordability solutions can help
By Emilie Signora | July 20, 2021
Earlier this year, PhRMA released a proactive agenda with common-sense, patient-centered reforms to improve access to quality, affordable health care. The urgency of building a stronger, more...
Read More
New reports shed light on key facts about medicines and affordability
By Brian Newell | June 8, 2021
A recently released report by IQVIA – an independent organization specializing in health care research – provides new data showing prices for brand medicines went down last year. The report offers...
Read More
Out-of-pocket trends in Medicare Part D show rising costs for seniors
By Katie Koziara | May 24, 2021
A new study based on IQVIA data shows alarming trends in rising out-of-pocket costs for brand medicines among Medicare Part D beneficiaries with serious and complex conditions like cancer, HIV and...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
